The public cost of HIV after Casanova's announcement

The price of making HIV visible: Casanova's announcement

Actor, director and screenwriter Eduardo Casanova has announced on social media that he is living with HIV and will tell his story in a documentary produced by Atresmedia and Producciones del Barrio, Jordi Évole's production company. At 34, he becomes the first public figure in Spain to make this condition public. The news not only reopens the conversation about stigma: it also brings to the forefront the real cost of HIV for Spain's public health system.

The annual treatment bill

The annual cost per patient, taking into account pharmaceutical expenses and those arising from the adverse effects of treatment, ranges between 6,788 and 10,649 euros. That, in the most expensive scenario, comes to around 10,000 euros per person per year. The figure has long been on the table in health economics analyses, but rarely leaves technical circles. Casanova's announcement has placed it in an unexpected spotlight.

It is no small expense for a country with a public health system. Every well-treated patient is an active person who pays into social security, but also a recurring cost the system assumes year after year. Antiretroviral medication has turned a deadly disease into a chronic one, and that success has a price that is rarely mentioned in headlines.

Undetectable, untransmittable and misunderstood

The discussion trinc the announcement has revealed significant confusion around the terms "undetectable" and "untransmittable". These concepts only apply to patients on continuous treatment with a suppressed viral load. Someone who does not know they are infected, and is not on medication, can transmit the bicho without knowing it. Part of the debate has ignored that technical distinction and mixed up concepts.

Scepticism about the economic component of the announcement has also emerged: the story will arrive in documentary format, which has raised questions about remuneration. But the uncomfortable argument for the system is another one. Late diagnosis multiplies hospitalisations and comorbidities, and that makes treatment far more expensive than early detection. Hiding the illness also costs money.

The most jarring data point came in the form of a question: "If it isn't transmitted, how did he catch it?" That confusion shows the scientific message has not sunk in as much as believed. While the public health system assumes thousands of euros per patient per year, part of public opinion still fails to understand what living with HIV means. The cost of ignorance, sometimes, is higher than the cost of medication.